Pharmafile Logo
Pharmafocus logo
Advanced Search

Immunology

Showing 15 posts of 75 posts found.

Gilead and Compugen enter exclusive license agreement for immunotherapy programme

December 20, 2023
Research and Development Gilead Sciences, Immunology, License Agreement, compugen, immunology

Gilead Sciences and Compugen have announced that they have entered an exclusive license agreement for Compugen’s potential first in class, …

News

BioNTech achieves milestone at vaccine manufacturing site in Rwanda

December 19, 2023
Manufacturing and Production BioNTech, Immunology, manufacturing, rwanda

BioNTech has announced that it has reached the next milestone in the establishment of its mRNA vaccine manufacturing capacities in …

News

AstraZeneca to acquire Icosavax for up to $1.1bn

December 12, 2023
Business Services AstraZeneca, Icosavax, Immunology, acquisition, immunology, vaccines

AstraZeneca has announced that it has entered into a definitive agreement to acquire Icosavax for approximately $15 per share or …

News

GSK shares new data for RSV vaccine Arexvy

October 25, 2023
Research and Development Arexvy, GSK, Immunology, RSV, Vaccine

GSK announced positive results from its phase 3 trial which assessed the immune response and safety of Arexvy, its respiratory …

News

AstraZeneca’s sBLA for FluMist Quadrivalent accepted by FDA

October 24, 2023
Medical Communications AstraZeneca, FDA, FluMist, Immunology, flu vaccine, sBLA

AstraZeneca has announced that the US Food and Drug Administration (FDA) has accepted for review its Supplemental Biologics License Agreement …

News

GSK and Zhifei partner for shingles vaccine promotion in China

October 9, 2023
Medical Communications GSK, Immunology, Shingrix, Vaccine, Zhifei, shingles

GSK has announced that it has come to an exclusive agreement with Chingqing Zhifei Biological Products to co-promote GSK’s shingles …

News

Janssen and Sanofi enter agreement for potential vaccine programme

October 5, 2023
Business Services Immunology, Janssen, Sanofi, e coli, vaccines

Janssen Pharmaceuticals, a Johnson & Johnson company, has announced a development and commercialisation agreement with Sanofi for Janssen’s extraintestinal pathogenic …

News
diana-polekhina-zbsthwt9vlc-unsplash_2

Moderna shares data from phase 1/2 trial for combination flu and COVID-19 vaccine

October 5, 2023
Research and Development COVID-19, Immunology, Moderna, clinical trial, influenza, vaccines

Moderna has announced positive interim results from the phase 1/2 trial of mRNA-1083, its investigational combination vaccine against influenza and …

News

WHO recommends new vaccine for prevention of malaria in children

October 3, 2023
Medical Communications Immunology, Vaccine, WHO, malaria, malaria vaccine

The World Health Organization (WHO) has announced that it has recommended a new vaccine, R21/Matrix-M, for the prevention of malaria …

News

BactiVac funds development of bacterial vaccines to prevent infections against antimicrobial resistance

September 28, 2023
Research and Development AMR, BactiVac, Immunology, vaccines

The University of Birmingham hosted Bacterial Vaccines Network has been awarded £1.4m in funding from the UK government to accelerate …

News

CDC Advisory Committee recommends Pfizer’s RSV vaccine

September 25, 2023
Medical Communications Abrysvo, Immunology, Pfizer, RSV

Pfizer has announced that the US Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) has …

News

Exscientia enters AI drug discovery collaboration with Merck KGaA

September 20, 2023
Business Services AI, Exscientia, Immunology, Merck KGaA, Neurology, Oncology, collaboration, drug discovery

Exscientia has announced a new collaboration with Merck KGaA, Darmstadt, Germany, with a focus on the discovery of novel small …

News

BioNTech and CEPI partner for development of mRNA mpox vaccine

September 19, 2023
Research and Development BioNTech, CEPI, Immunology, mpox

BioNTech and the Coalition for Epidemic Preparedness Innovations (CEPI) have announced a partnership to advance the development of mRNA-based vaccine …

News

GSK and Save the Children extend partnership for unvaccinated children

September 15, 2023
Medical Communications GSK, Immunology, childhood vaccination, vaccines

GSK and Save the Children have announced that they will be renewing their partnership for an additional five years. GSK …

News

ACM Biolabs shares positive results from phase 1 SARS-CoV-2 booster vaccine trial

September 5, 2023
Research and Development ACM Biolabs, COVID-19, Immunology, SARS-CoV-2, Vaccine, clinical trial

ACM Biolabs has announced positive topline results from its phase 1 trial of ACM-001, an adjuvanted booster vaccine for SARS-CoV-2, …

News
The Gateway to Local Adoption Series

Latest content

Just – Evotec given Gates Foundation grant to increase global biotherapeutics access

January 8, 2026

Johnson & Johnson submits robotic surgical system for De Novo classification

January 8, 2026

EA Pharma announces phase 3 trial for new schizophrenia treatment in Japan

January 7, 2026

Eleva appoints Erich Rajkovic as Chief Business Officer

January 7, 2026

MedPharm announces US FDA inspection of North Carolina manufacturing facility

January 6, 2026